UNSPSC 51372802: Quadazocine

This classification denotes an opioid receptor agonist and opiate antagonist with the molecular formula C25H37NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, X9BMD58553 chemically known as (-)-(2r,6s,11s)-1-cyclopentyl-5-(1,2,3,4,5,6-hexahydro-8-hydroxy-3,6,11-trimethyl-2,6-methano-3-benzazocin-11-yl)-3-pentanone but generally known as quadazocine, which bears US NIH Compound Identifier 115077.

UNSPSC 51372802 Quadazocine is a Commodity code that does not align with the state and local opportunities tagged under it. The recent solicitations involve naloxone (a distinct opioid antagonist), generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription programs—none of which address quadazocine specifically. The code shows little relevant recent activity; the mismatch between the code's nominal scope and actual procurement tagged under it suggests either misclassification in the source data or that quadazocine itself generates minimal state and local demand.

The three opportunities posted since January 2026 reflect broader pharmaceutical and health-supply sourcing by state and local issuing bodies. Seminole County, Florida (IFB60459723LAS, due July 26, 2023) is procuring naloxone and drug deactivation systems through an IFB with quarterly deliveries to its Community Health Building. The Texas Health and Human Services Commission issued an RFI in April 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program. Minnesota's Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP in January 2026 (due March 26, 2026) for generic pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon through authorized wholesalers. The MMCAP solicitation drives awards based on pricing competitiveness (75 percent weight), with a two-year initial term and optional extensions. No recent opportunities explicitly solicit quadazocine; state and local procurement under this code warrants close monitoring to determine whether activity emerges.